Acumen Pharmaceuticals, Inc.
ABOS
$1.36
-$0.05-3.55%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -40.95M | -28.80M | -37.15M | -29.77M | -20.54M |
| Total Depreciation and Amortization | 47.00K | 45.00K | 44.00K | 45.00K | 45.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.80M | 1.99M | 1.67M | 1.39M | 182.00K |
| Change in Net Operating Assets | 6.28M | -7.36M | 8.22M | 3.73M | 3.77M |
| Cash from Operations | -31.83M | -34.12M | -27.22M | -24.60M | -16.55M |
| Capital Expenditure | -9.00K | -79.00K | 0.00 | 0.00 | -5.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 38.49M | 28.77M | 29.66M | -10.13M | 37.70M |
| Cash from Investing | 38.48M | 28.69M | 29.66M | -10.13M | 37.70M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | 0.00 | 37.00K | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Stock | 0.00 | -73.00K | -9.00K | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | -42.00K | -128.00K |
| Cash from Financing | 0.00 | -36.00K | -9.00K | -42.00K | -128.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.65M | -5.47M | 2.44M | -34.77M | 21.03M |